(Q34269191)

1 August 2017

1 reference

title

Paraoxonase gene polymorphisms, oxidative stress, and diseases (English)

1 reference

1 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551701

20 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00109-003-0481-4

20 March 2024

2

De-Pei Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551701

20 March 2024

author name string

Hong-Liang Li

series ordinal

1

1 reference

1 August 2017

Chih-Chuan Liang

series ordinal

3

1 reference

1 August 2017

language of work or name

1 reference

9 October 2003

1 reference

full work available at URL

1 August 2017

http://link.springer.com/content/pdf/10.1007/s00109-003-0481-4.pdf

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00109-003-0481-4

http://link.springer.com/article/10.1007/s00109-003-0481-4/fulltext.html

20 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00109-003-0481-4

http://link.springer.com/content/pdf/10.1007/s00109-003-0481-4

20 March 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1007/S00109-003-0481-4

Journal of Molecular Medicine

20 March 2024

published in

1 reference

1 August 2017

volume

81

1 reference

1 August 2017

issue

12

1 reference

1 August 2017

page(s)

766-779

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-003-0481-4

1 August 2017

exact match

0 references

cites work

Comment--to: Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J (2001) Paraoxonase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107

1 reference

12 December 2020

Expression of human paraoxonase (PON1) during development.

1 reference

12 December 2020

Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes.

1 reference

12 December 2020

Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus

1 reference

12 December 2020

Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites

1 reference

12 December 2020

The MTHFR C677T, APOE, and PON55 gene polymorphisms show relevant interactions with cardiovascular risk factors.

1 reference

12 December 2020

Paraoxonase genes and disease

1 reference

12 December 2020

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

1 reference

12 December 2020

Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.

1 reference

12 December 2020

Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study

1 reference

12 December 2020

Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.

1 reference

12 December 2020

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

12 December 2020

Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?

1 reference

12 December 2020

Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip.

1 reference

12 December 2020

Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response

1 reference

12 December 2020

Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease

1 reference

12 December 2020

Paraoxonase polymorphisms and organophosphates.

1 reference

12 December 2020

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

1 reference

12 December 2020

Association of PON2 variation with birth weight in Trinidadian neonates of South Asian ancestry

1 reference

12 December 2020

Paraoxonase and atherosclerosis

1 reference

12 December 2020

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

1 reference

12 December 2020

PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients

1 reference

12 December 2020

Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?

1 reference

12 December 2020

Variability of the paraoxonase gene (PON1) in Euro- and Afro-Brazilians

1 reference

12 December 2020

Oligomeric states of the detergent-solubilized human serum paraoxonase (PON1)

1 reference

12 December 2020

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

12 December 2020

The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein.

1 reference

12 December 2020

Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease

1 reference

12 December 2020

Vitamin C and E intake is associated with increased paraoxonase activity

1 reference

12 December 2020

Rabbits possess a serum paraoxonase polymorphism similar to the human Q192R

1 reference

12 December 2020

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

1 reference

12 December 2020

Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration

1 reference

12 December 2020

Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism

1 reference

12 December 2020

Structural and functional diversity of paraoxonases

1 reference

12 December 2020

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

12 December 2020

Pharmacogenomic considerations of the paraoxonase polymorphisms

1 reference

12 December 2020

Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.

1 reference

12 December 2020

Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

1 reference

12 December 2020

Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism

1 reference

12 December 2020

Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke

1 reference

12 December 2020

The paraoxonase gene family and coronary heart disease

1 reference

12 December 2020

High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients

1 reference

12 December 2020

Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role

1 reference

12 December 2020

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

1 reference

12 December 2020

Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.

1 reference

12 December 2020

No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population

1 reference

12 December 2020

Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol

1 reference

12 December 2020

Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease.

1 reference

12 December 2020

LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects

1 reference

12 December 2020

Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis.

1 reference

12 December 2020

The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.

1 reference

12 December 2020

Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes

1 reference

12 December 2020

Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease.

1 reference

12 December 2020

Paraoxonase 192 Gln-->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults.

1 reference

12 December 2020

Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins

1 reference

12 December 2020

Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease.

1 reference

12 December 2020

Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson's disease

1 reference

12 December 2020

Analysis of association between the Gln192Arg polymorphism of the paraoxonase gene and schizophrenia in humans

1 reference

12 December 2020

Many South Asian people probably need pre-diabetes care.

1 reference

12 December 2020

Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias

1 reference

12 December 2020

The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients

1 reference

12 December 2020

PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population

1 reference

12 December 2020

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

12 December 2020

Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians

1 reference

12 December 2020

Size at birth and coronary artery disease in a population with high birth weight

1 reference

12 December 2020

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection

1 reference

12 December 2020

Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm

1 reference

12 December 2020

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

1 reference

12 December 2020

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities

1 reference

12 December 2020

Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite

1 reference

12 December 2020

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

1 reference

12 December 2020

Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism

1 reference

12 December 2020

No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy.

1 reference

12 December 2020

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

1 reference

12 December 2020

Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.

1 reference

12 December 2020

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

1 reference

12 December 2020

Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials

1 reference

12 December 2020

Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine.

1 reference

12 December 2020

Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women

1 reference

12 December 2020

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

1 reference

12 December 2020

Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk

1 reference

12 December 2020

Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians

1 reference

12 December 2020

Polymorphisms in the human paraoxonase (PON1) promoter

1 reference

12 December 2020

Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations

1 reference

12 December 2020

High intakes of vegetables, berries, and apples combined with a high intake of linoleic or oleic acid only slightly affect markers of lipid peroxidation and lipoprotein metabolism in healthy subjects

1 reference

12 December 2020

Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients

1 reference

12 December 2020

A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.

1 reference

12 December 2020

Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human

1 reference

12 December 2020

Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.

1 reference

12 December 2020

The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene

1 reference

12 December 2020

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

1 reference

12 December 2020

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

1 reference

12 December 2020

Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study

1 reference

12 December 2020

Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide

1 reference

12 December 2020

Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia

1 reference

12 December 2020

Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases

1 reference

12 December 2020

Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus

1 reference

12 December 2020

Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6.

1 reference

12 December 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1022859035

0 references

1 reference